When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa
| dc.contributor.author | Schomaker, Michael | en_ZA |
| dc.contributor.author | Egger, Matthias | en_ZA |
| dc.contributor.author | Ndirangu, James | en_ZA |
| dc.contributor.author | Phiri, Sam | en_ZA |
| dc.contributor.author | Moultrie, Harry | en_ZA |
| dc.contributor.author | Technau, Karl | en_ZA |
| dc.contributor.author | Cox, Vivian | en_ZA |
| dc.contributor.author | Giddy, Janet | en_ZA |
| dc.contributor.author | Chimbetete, Cleophas | en_ZA |
| dc.contributor.author | Wood, Robin | en_ZA |
| dc.date.accessioned | 2015-11-16T04:09:41Z | |
| dc.date.available | 2015-11-16T04:09:41Z | |
| dc.date.issued | 2013 | en_ZA |
| dc.description.abstract | Michael Schomaker and colleagues estimate the mortality associated with starting ART at different CD4 thresholds among children aged 2-5 years using observational data collected in cohort studies in Southern Africa. Please see later in the article for the Editors' Summary | en_ZA |
| dc.identifier.apacitation | Schomaker, M., Egger, M., Ndirangu, J., Phiri, S., Moultrie, H., Technau, K., ... Wood, R. (2013). When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. <i>PLOS Medicince</i>, http://hdl.handle.net/11427/15006 | en_ZA |
| dc.identifier.chicagocitation | Schomaker, Michael, Matthias Egger, James Ndirangu, Sam Phiri, Harry Moultrie, Karl Technau, Vivian Cox, Janet Giddy, Cleophas Chimbetete, and Robin Wood "When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa." <i>PLOS Medicince</i> (2013) http://hdl.handle.net/11427/15006 | en_ZA |
| dc.identifier.citation | Schomaker, M., Egger, M., Ndirangu, J., Phiri, S., Moultrie, H., Technau, K., ... & Davies, M. A. (2013). When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS medicine, 10(11), e1001555. doi:10.1371/journal.pmed.1001555 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Schomaker, Michael AU - Egger, Matthias AU - Ndirangu, James AU - Phiri, Sam AU - Moultrie, Harry AU - Technau, Karl AU - Cox, Vivian AU - Giddy, Janet AU - Chimbetete, Cleophas AU - Wood, Robin AB - Michael Schomaker and colleagues estimate the mortality associated with starting ART at different CD4 thresholds among children aged 2-5 years using observational data collected in cohort studies in Southern Africa. Please see later in the article for the Editors' Summary DA - 2013 DB - OpenUCT DO - 10.1371/journal.pmed.1001555 DP - University of Cape Town J1 - PLOS Medicince LK - https://open.uct.ac.za PB - University of Cape Town PY - 2013 T1 - When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa TI - When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa UR - http://hdl.handle.net/11427/15006 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/15006 | |
| dc.identifier.uri | http://dx.doi.org/10.1371/journal.pmed.1001555 | |
| dc.identifier.vancouvercitation | Schomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technau K, et al. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLOS Medicince. 2013; http://hdl.handle.net/11427/15006. | en_ZA |
| dc.language.iso | eng | en_ZA |
| dc.publisher | Public Library of Science | en_ZA |
| dc.publisher.department | Institute of Infectious Disease and Molecular Medicine | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en_ZA |
| dc.rights.holder | © 2013 Schomaker et al | en_ZA |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | en_ZA |
| dc.source | PLOS Medicince | en_ZA |
| dc.source.uri | http://journals.plos.org/plosmedicine | en_ZA |
| dc.subject.other | Children | en_ZA |
| dc.subject.other | Antiretroviral therapy | en_ZA |
| dc.subject.other | HIV | en_ZA |
| dc.subject.other | AIDS | en_ZA |
| dc.subject.other | HIV infections | en_ZA |
| dc.subject.other | Death rates | en_ZA |
| dc.subject.other | Africa | en_ZA |
| dc.subject.other | HIV epidemiology | en_ZA |
| dc.title | When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Schomaker_When_to_Start_ART_2013.pdf
- Size:
- 601.81 KB
- Format:
- Adobe Portable Document Format
- Description: